Project Details
Description
A Double Blind, Placebo-Controlled Study of the Efficacy and Safety of CORLUX (Mifepristone) vs. Placebo in the Treatment of Psychotic Symptoms in Patients with Major depressive Disorder with Psychotic Features
| Status | Finished |
|---|---|
| Effective start/end date | 4/7/09 → 4/14/11 |
Funding
- ICON CLINICAL RESEARCH, INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.